This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: Merck Sharp & Dohme Corp. and Canji, Inc., Merck Sharp + Dohme Corp., Schering Corporation. Active years: 2010-2014.
Location History:
- Ithaca, NY (US) (2010)
- San Diego, CA (US) (2012 - 2014)
Company Filing History:


Years Active: 2010-2014
Title: Sameer Goregaoker: Innovator in RNA Interference Technology
Introduction
Sameer Goregaoker is a prominent inventor based in San Diego, CA. He has made significant contributions to the field of biotechnology, particularly in the area of RNA interference (RNAi). With a total of 3 patents, his work focuses on innovative methods to inhibit gene expression and address chronic pain.
Latest Patents
Sameer Goregaoker's latest patents involve the development of short interfering nucleic acids, which can be either single-stranded or double-stranded. These inventions facilitate RNAi-induced degradation of mRNA from the Na1.8 sodium channel gene. His patents also encompass pharmaceutical compositions that include these short interfering nucleic acids, as well as recombinant vectors. Additionally, he has devised methods for inhibiting translation of mRNA, blocking membrane potential in cells, and inhibiting sodium current, all aimed at alleviating chronic pain.
Career Highlights
Throughout his career, Sameer has worked with notable companies such as Merck Sharp & Dohme Corp. and Schering Corporation. His experience in these organizations has allowed him to refine his expertise in biotechnology and contribute to groundbreaking research.
Collaborations
Sameer has collaborated with esteemed colleagues, including John C. Hunter and Tony Priestley. These partnerships have further enhanced his innovative capabilities and expanded the impact of his work in the field.
Conclusion
Sameer Goregaoker is a distinguished inventor whose work in RNA interference technology has the potential to revolutionize treatments for chronic pain. His contributions to biotechnology continue to pave the way for future innovations in the field.